Windtree Therapeutics Targets $520 Million in Funding to Secure BNB Reserve
Windtree Therapeutics (WINT), a publicly listed biotechnology company, announced today that it has entered into two significant financial agreements to raise up to $520 million for the acquisition of BNB (BNB). Overall, the firm has earmarked nearly $700 million to buy BNB, the fifth-largest cryptocurrency by market capitalization. Windtree Commits $520 Million to Build a…
